| Penulis/Author |
Prof. dr. Eggi Arguni, M.Sc., Ph.D., Sp.A(K). (1) ; Endah Supriyati (2); dr. Mohamad Saifudin Hakim, M.Sc, Ph.D. (3); dr. Marselinus Edwin Widyanto Daniwijaya, Ph.D., Sp. MK (4); Chi Won Suk (5); Ayu Rahayu, S.Si., M.Si. (6); Anwar Rovik (7); Utari Saraswati (8); dr. Farida Nur Oktoviani (9); dr. Nenes Prastiwi (10); Prof. dr. Titik Nuryastuti, M.Si., Ph.D., Sp.MK(K). (11); Prof. dr. Tri Wibawa, Ph.D., Sp.MK(K) (12); Prof. dr. Sofia Mubarika Harjana, M.Med.Sc., Ph.D. (13) |
| Abstrak/Abstract |
Background: Growing evidence shows that viral co-infection is found repeatedly in patients with Coronavirus Disease–2019 (COVID-19). This is the first report of SARS-CoV-2 co-infection with viral respiratory pathogens in Indonesia.
Methods: Over a one month period of April to May 2020, SARS-CoV-2 positive nasopharyngeal swabs in our COVID-19 referral laboratory in Yogyakarta, Indonesia, were tested for viral respiratory pathogens by real-time, reverse transcription polymerase chain reaction (RT-PCR). Proportion of co-infection reported in percentage. Results: Fifty-nine samples were positive for other viral respiratory pathogens among a total of 125 samples. Influenza A virus was detected in 32 samples, Influenza B in 16 samples, Human metapneumovirus in 1 sample, and adenovirus in 10 samples. We did not detect any co-infection with respiratory syncytial virus. Nine (7.2%) patients had co-infection with more than two viruses.
Conclusion: Viral co-infection with SARS-CoV-2 is common. These results will provide a helpful reference for diagnosis and clinical treatment of patients with COVID-19. |
